CBD (Cannabidiol) and Degenerative Diseases: Potential Benefits Explained

CBD and Neurodegenerative Disorders: What Science Says

Neurodegenerative disorders involve the progressive and irreversible loss of neurons in certain areas of the brain. In recent years, scientific research has increasingly explored how cannabis and its extracts, particularly CBD (cannabidiol), may offer therapeutic benefits for a range of these conditions.

Major Neurodegenerative Disorders

Some of the most well-known neurodegenerative diseases include:

• Alzheimer’s Disease

• Parkinson’s Disease

• Huntington’s Disease

• Amyotrophic Lateral Sclerosis (ALS)

• Progressive Supranuclear Palsy

• Frontotemporal Dementia

• Lewy Body Dementia

• Creutzfeldt-Jakob Disease (CJD)

What Does the Research Show?

Ethan Russo, Director of the R&D International Cannabis and Cannabinoid Institute, spoke on this topic during the Balkannabis Expo in Athens, a three-day event dedicated to the latest research on cannabis and its therapeutic properties.

Russo explained to Sanità InFormazione (a healthcare-focused daily publication):

“Cannabidiol is a highly effective medical compound for many conditions. It has powerful anti-inflammatory properties, which help reduce pain and inflammation, and it can also protect the brain from injuries such as cranial trauma and strokes. Emerging evidence suggests that CBD may offer neuroprotective effects against degenerative diseases like Alzheimer’s and other forms of dementia. Additionally, CBD has shown high efficacy in managing severe convulsions. In the United States, a medical drug containing cannabidiol is awaiting approval and is expected to be released next month.”